Early initiation of sodium‐glucose linked transporter inhibitors (SGLT‐2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients

There is a paucity of data on the use of SGLT2 inhibitors on outcomes in kidney transplant recipients. There may be concern in initiating these agents, especially within the first year post‐transplant when renal function is more labile and immunosuppression more intense, due to a presumed high risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Chelsey Chenxi, Brown, Andrew, Winstead, Ryan, Yakubu, Idris, Demehin, Moses, Kumar, Dhiren, Gupta, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029504/
https://www.ncbi.nlm.nih.gov/pubmed/33855198
http://dx.doi.org/10.1002/edm2.185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029504/
https://www.ncbi.nlm.nih.gov/pubmed/33855198
http://dx.doi.org/10.1002/edm2.185

Ejemplares similares